JOSHUA HANSEN: Open Payments
NPI 1588948087 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 93 payments from 22 companies in 2025. Trend: 2023 $1,439 · 2024 $1,450 · 2025 $1,608
Food & beverage: $1,608
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $353 |
| Aimmune Therapeutics, Inc. | 7 | $162 |
| Amgen Inc. | 13 | $136 |
| Vanda Pharmaceuticals Inc. | 5 | $122 |
| Otsuka America Pharmaceutical, Inc. | 6 | $110 |
| Lilly USA, LLC | 5 | $94 |
| Phathom Pharmaceuticals, Inc. | 5 | $72 |
| Lundbeck LLC | 3 | $69 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
Products named: VRAYLAR, REXULTI, QULIPTA, FANAPT, ZENPEP, MOUNJARO, VOQUEZNA, GEMTESA.
Industry payments across ID — which companies pay providers there.
